subject: Giantcode Corp [print this page] Giantcode Corp Giantcode Corp
GiantCode Corp,focused on the development technology to provide resistance against kidney cancer.
Giantcode Plc, with its principle website www.giantcodecop.com is a subsidiary of Giantcode Corp, Singapore. United Kingdom is the home to its registered office. Giantcode Corp primarily focuses on the development of a series of clinical objects that would provide resistance against kidney cancer, prostate cancer, liver cancer, pancreatic cancer, gastro-intestinal cancers and lung cancer. Such types of cancers are life threatening as the treatments and medicines of today are not apt for its treatment. Giantcode Corp primary aim is to improve the health condition of the cancer patients through the innovation of treatments that would cure cancer diseases.
Giantcode Corp works with other groups and organizes internal as well as external programs dedicated to the clinical and pre- clinical activities. At the preclinical stage of development we make an effort as far as strategic alliance is concerned for new discoveries. Giantcode Corp's R & D programs are modified to be most effective for treatments that are available at a reduced cost. We are also able to incorporate the technologies that would suit the needs of our partners who follow a strategic method.
The R&D approach of Giantcode Corp, www.giantcodecorp.com, is basically based on the approach of employing an individual well versed with scientific knowledge in the lab. This company comprises a group of personnel who are backed up by experience in the fields of pharmacy, finance and science.
